{"nct_id":"NCT03900429","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-02","start_date":"2019-03-28","start_date_type":"ACTUAL","primary_completion_date":"2028-01","primary_completion_date_type":"ESTIMATED","completion_date":"2028-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MDGL"]}